{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:30:29Z","timestamp":1782603029226,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00198-019-05067-7","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T10:02:47Z","timestamp":1566381767000},"page":"2417-2428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy\u2014a long-term radiological follow-up"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-3140","authenticated-orcid":false,"given":"M.A.","family":"Png","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.B.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.Y.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"5067_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294\u20131301. \nhttps:\/\/doi.org\/10.1210\/jc.2004-0952","journal-title":"J Clin Endocrinol Metab"},{"key":"5067_CR2","first-page":"77","volume":"52","author":"JSB Koh","year":"2011","unstructured":"Koh JSB, Goh SK, Png MA, Ng ACM, Howe TS (2011) Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology. Singap Med J 52:77\u201380","journal-title":"Singap Med J"},{"key":"5067_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","volume":"39","author":"EBK Kwek","year":"2008","unstructured":"Kwek EBK, Goh SK, Koh JSB, Png MA, Sen HT (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39:224\u2013231. \nhttps:\/\/doi.org\/10.1016\/j.injury.2007.08.036","journal-title":"Injury"},{"key":"5067_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","volume":"22","author":"AS Neviaser","year":"2008","unstructured":"Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346\u2013350. \nhttps:\/\/doi.org\/10.1097\/BOT.0b013e318172841c","journal-title":"J Orthop Trauma"},{"key":"5067_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O\u2019Keefe R, Papapoulos S, Sen HT, Van Der Meulen MCH, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American society for bone and mineral research. J Bone Miner Res 29:1\u201323. \nhttps:\/\/doi.org\/10.1002\/jbmr.1998","journal-title":"J Bone Miner Res"},{"key":"5067_CR6","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1007\/s11999-010-1535-x","volume":"468","author":"JD Isaacs","year":"2010","unstructured":"Isaacs JD, Shidiak L, Harris IA, Szomor ZL (2010) Femoral insufficiency fractures associated with prolonged bisphosphonate therapy. Clin Orthop Relat Res 468:3384\u20133392. \nhttps:\/\/doi.org\/10.1007\/s11999-010-1535-x","journal-title":"Clin Orthop Relat Res"},{"key":"5067_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2106\/JBJS.K.01181","volume":"95","author":"BJ Edwards","year":"2013","unstructured":"Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy JM, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH (2013) Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts. J Bone Jt Surg-Am 95:297\u2013307. \nhttps:\/\/doi.org\/10.2106\/JBJS.K.01181","journal-title":"J Bone Jt Surg-Am"},{"key":"5067_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/BOT.0b013e3181b6499b","volume":"24","author":"JSB Koh","year":"2010","unstructured":"Koh JSB, Goh SK, Png MA, Kwek EBK, Sen HT (2010) Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma 24:75\u201381. \nhttps:\/\/doi.org\/10.1097\/BOT.0b013e3181b6499b","journal-title":"J Orthop Trauma"},{"key":"5067_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2214\/AJR.11.6794","volume":"198","author":"MA Png","year":"2012","unstructured":"Png MA, Koh JSB, Goh SK, Fook-Chong S, Sen HT (2012) Bisphosphonate-related femoral periosteal stress reactions: scoring system based on radiographic and MRI findings. Am J Roentgenol 198:869\u2013877. \nhttps:\/\/doi.org\/10.2214\/AJR.11.6794","journal-title":"Am J Roentgenol"},{"key":"5067_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11420-012-9275-y","volume":"8","author":"A Saleh","year":"2012","unstructured":"Saleh A, Hegde VV, Potty AG, Schneider R, Cornell CN, Lane JM (2012) Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures. HSS J 8:103\u2013110. \nhttps:\/\/doi.org\/10.1007\/s11420-012-9275-y","journal-title":"HSS J"},{"key":"5067_CR11","doi-asserted-by":"publisher","first-page":"jc2016","DOI":"10.1210\/jc.2016-2787","volume":"102","author":"B-W Min","year":"2016","unstructured":"Min B-W, Koo K-H, Park Y-S, Oh C-W, Lim S-J, Kim J-W, Lee K-J, Lee Y-K (2016) Novel scoring system for identifying impending complete fractures in incomplete atypical femoral fractures. J Clin Endocrinol Metab 102:jc2016\u2013jc2787. \nhttps:\/\/doi.org\/10.1210\/jc.2016-2787","journal-title":"J Clin Endocrinol Metab"},{"key":"5067_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jacr.2017.03.005","volume":"14","author":"A Min","year":"2017","unstructured":"Min A, Chan VWY, Aristizabal R, Peramaki ER, Agulnik DB, Strydom N, Ramsey D, Forster BB (2017) Clinical decision support decreases volume of imaging for low back pain in an urban emergency department. J Am Coll Radiol 14:889\u2013899. \nhttps:\/\/doi.org\/10.1016\/j.jacr.2017.03.005","journal-title":"J Am Coll Radiol"},{"key":"5067_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00330-012-2587-y","volume":"23","author":"PC Mohan","year":"2013","unstructured":"Mohan PC, Howe TS, Koh JSB, Png MA (2013) Radiographic features of multifocal endosteal thickening of the femur in patients on long-term bisphosphonate therapy. Eur Radiol 23:222\u2013227. \nhttps:\/\/doi.org\/10.1007\/s00330-012-2587-y","journal-title":"Eur Radiol"},{"key":"5067_CR14","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1210\/jc.2012-4322","volume":"98","author":"Y-KK Lee","year":"2013","unstructured":"Lee Y-KK, Ha Y-CC, Kang BJ, Chang JS, Koo K-HH (2013) Predicting need for fixation of atypical femoral fracture. J Clin Endocrinol Metab 98:2742\u20132745. \nhttps:\/\/doi.org\/10.1210\/jc.2012-4322","journal-title":"J Clin Endocrinol Metab"},{"key":"5067_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1302\/0301-620X.99B3.BJJ-2016-0276.R2","volume":"99B","author":"A Koh","year":"2017","unstructured":"Koh A, Guerado E, Giannoudis PV (2017) Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management. Bone Jt J 99B:295\u2013302. \nhttps:\/\/doi.org\/10.1302\/0301-620X.99B3.BJJ-2016-0276.R2","journal-title":"Bone Jt J"},{"key":"5067_CR16","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1007\/s11999-013-2963-1","volume":"472","author":"KA Egol","year":"2014","unstructured":"Egol KA, Park JH, Rosenberg ZS, Peck V, Tejwani NC (2014) Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res 472:2728\u20132734. \nhttps:\/\/doi.org\/10.1007\/s11999-013-2963-1","journal-title":"Clin Orthop Relat Res"},{"key":"5067_CR17","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s11999-010-1583-2","volume":"468","author":"YC Ha","year":"2010","unstructured":"Ha YC, Cho MR, Park KH, Kim SY, Koo KH (2010) Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy? Clin Orthop Relat Res 468:3393\u20133398. \nhttps:\/\/doi.org\/10.1007\/s11999-010-1583-2","journal-title":"Clin Orthop Relat Res"},{"key":"5067_CR18","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1210\/jc.2010-2520","volume":"96","author":"SJ Gomberg","year":"2011","unstructured":"Gomberg SJ, Wustrack RL, Napoli N, Arnaud CD, Black DM (2011) Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. J Clin Endocrinol Metab 96:1627\u20131632. \nhttps:\/\/doi.org\/10.1210\/jc.2010-2520","journal-title":"J Clin Endocrinol Metab"},{"key":"5067_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","volume":"86","author":"J Schilcher","year":"2015","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Micha\u00eblsson K (2015) Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop 86:100\u2013107. \nhttps:\/\/doi.org\/10.3109\/17453674.2015.1004149","journal-title":"Acta Orthop"},{"key":"5067_CR20","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jbmr.3420","volume":"33","author":"AL Adams","year":"2018","unstructured":"Adams AL, Adams JL, Raebel MA, Tang BT, Kuntz JL, Vijayadeva V, McGlynn EA, Gozansky WS (2018) Bisphosphonate drug holiday and fracture risk: a population-based cohort study. J Bone Miner Res 33:1252\u20131259. \nhttps:\/\/doi.org\/10.1002\/jbmr.3420","journal-title":"J Bone Miner Res"},{"key":"5067_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/jbmr.2107","volume":"29","author":"MB Zanchetta","year":"2014","unstructured":"Zanchetta MB, Diehl M, Buttazzoni M, Galich A, Silveira F, Bogado CE, Zanchetta JR (2014) Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur. J Bone Miner Res 29:999\u20131004. \nhttps:\/\/doi.org\/10.1002\/jbmr.2107","journal-title":"J Bone Miner Res"},{"key":"5067_CR22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jc.2009-1947","volume":"95","author":"NB Watts","year":"2010","unstructured":"Watts NB, Diab DL (2010) Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 95:1555\u20131565. \nhttps:\/\/doi.org\/10.1210\/jc.2009-1947","journal-title":"J Clin Endocrinol Metab"},{"key":"5067_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/ep.16.s3.1","volume":"16","author":"N Watts","year":"2010","unstructured":"Watts N, Bilezikian J, Camacho P, Greenspan S, Harris S, Hodgson S, Kleerekoper M, Luckey M, McClung M, Pollack R, Petak S (2010) American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16:1\u201337. \nhttps:\/\/doi.org\/10.4158\/ep.16.s3.1","journal-title":"Endocr Pract"},{"key":"5067_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jbmr.1494","volume":"27","author":"JE Compston","year":"2012","unstructured":"Compston JE, Bilezikian JP (2012) Bisphosphonate therapy for osteoporosis: the long and short of it. J Bone Miner Res 27:240\u2013242. \nhttps:\/\/doi.org\/10.1002\/jbmr.1494","journal-title":"J Bone Miner Res"},{"key":"5067_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4158\/EP171975.OR","volume":"24","author":"B Bindon","year":"2018","unstructured":"Bindon B, Adams W, Balasubramanian N, Sandhu J, Camacho P (2018) Osteoporotic fractures during bisphosphonate drug holiday. Endocr Pract 24:163\u2013169. \nhttps:\/\/doi.org\/10.4158\/EP171975.OR","journal-title":"Endocr Pract"},{"key":"5067_CR26","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1007\/s11999-011-1828-8","volume":"469","author":"MB Banffy","year":"2011","unstructured":"Banffy MB, Vrahas MS, Ready JE, Abraham JA (2011) Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures. Clin Orthop Relat Res 469:2028\u20132034. \nhttps:\/\/doi.org\/10.1007\/s11999-011-1828-8","journal-title":"Clin Orthop Relat Res"},{"key":"5067_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/BOT.0b013e31827240ae","volume":"27","author":"KA Egol","year":"2013","unstructured":"Egol KA, Park JH, Prensky C, Rosenberg ZS, Peck V, Tejwani NC (2013) Surgical treatment improves clinical and functional outcomes for patients who sustain incomplete bisphosphonate-related femur fractures. J Orthop Trauma 27:331\u2013335","journal-title":"J Orthop Trauma"},{"key":"5067_CR28","doi-asserted-by":"publisher","first-page":"450148","DOI":"10.1155\/2013\/450148","volume":"2013","author":"C-W Oh","year":"2013","unstructured":"Oh C-W, Oh J-K, Park K-C, Kim J-W, Yoon Y-C (2013) Prophylactic nailing of incomplete atypical femoral fractures. SciWorld J 2013:450148. \nhttps:\/\/doi.org\/10.1155\/2013\/450148","journal-title":"SciWorld J"},{"key":"5067_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/TA.0b013e31821957e3","volume":"71","author":"YA Weil","year":"2011","unstructured":"Weil YA, Rivkin G, Safran O, Liebergall MFA (2011) The outcome of surgically treated femur fractures associated. J Trauma 71:186\u2013190. \nhttps:\/\/doi.org\/10.1097\/TA.0b013e31821957e3","journal-title":"J Trauma"},{"key":"5067_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1302\/0301-620X.96B5.32887","volume":"96 B","author":"BJX Teo","year":"2014","unstructured":"Teo BJX, Koh JSB, Goh SK, Png MA, Chua DTC, Howe TS (2014) Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Jt J 96 B:658\u2013664","journal-title":"Bone Jt J"},{"key":"5067_CR31","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s11999-012-2412-6","volume":"470","author":"ML Prasarn","year":"2012","unstructured":"Prasarn ML, Ahn J, Helfet DL, Lane JM, Lorich DG (2012) Bisphosphonate-associated femur fractures have high complication rates with operative fixation trauma. Clin Orthop Relat Res 470:2295\u20132301. \nhttps:\/\/doi.org\/10.1007\/s11999-012-2412-6","journal-title":"Clin Orthop Relat Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05067-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05067-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05067-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T23:42:56Z","timestamp":1597880576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05067-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5067"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05067-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The retrospective cohort study was approved by our institutional review board with waiver of informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Meng Ai Png, P. Chandra Mohan, Choong Yin Howe and Tet Sen Howe declare that they have no conflict of interest.Joyce S.B. Koh has received Overseas conference sponsor from Amgen Dec 2017 and Chairperson fee from Amgen Nov 2018. Amgen produces and markets Denosumab.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}